| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 888.87M | 866.67M | 764.38M | 684.26M | 648.07M | 508.84M |
| Gross Profit | 230.57M | 234.62M | 218.94M | 244.19M | 224.28M | 166.54M |
| EBITDA | 9.88M | -35.72M | -46.04M | 658.00K | 74.44M | 108.73M |
| Net Income | -47.29M | -93.46M | -104.75M | -75.33M | -65.20M | -29.40M |
Balance Sheet | ||||||
| Total Assets | 837.13M | 793.84M | 810.91M | 977.31M | 1.29B | 1.53B |
| Cash, Cash Equivalents and Short-Term Investments | 47.48M | 52.50M | 44.32M | 71.88M | 80.57M | 258.84M |
| Total Debt | 461.94M | 456.40M | 451.27M | 512.44M | 565.59M | 690.74M |
| Total Liabilities | 620.09M | 579.32M | 588.35M | 650.00M | 887.41M | 1.06B |
| Stockholders Equity | 217.04M | 214.52M | 222.56M | 327.31M | 402.64M | 467.84M |
Cash Flow | ||||||
| Free Cash Flow | -16.58M | -34.23M | 55.42M | -4.98M | -156.86M | -21.57M |
| Operating Cash Flow | 37.98M | 31.53M | 88.64M | 15.46M | -135.29M | -12.47M |
| Investing Cash Flow | -50.91M | -65.54M | -32.89M | 55.94M | 113.42M | 300.93M |
| Financing Cash Flow | 25.54M | 42.19M | -83.31M | -80.09M | -156.41M | -54.46M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$989.78M | 8.29 | 5.08% | 10.44% | -1.19% | -9.05% | |
71 Outperform | HK$295.00M | 11.17 | 5.48% | 0.78% | 5.43% | -25.42% | |
68 Neutral | HK$2.30B | 10.33 | 13.72% | 3.74% | 11.89% | 27.80% | |
64 Neutral | HK$460.65M | 9.63 | 4.62% | 13.51% | 2.82% | -22.62% | |
63 Neutral | HK$981.63M | 93.53 | 0.79% | 0.00% | -1.70% | 104.41% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
38 Underperform | HK$436.83M | -8.51 | -23.87% | ― | 4.72% | 79.88% |
Labixiaoxin Snacks Group Ltd. has entered into a Purchase Agreement with Jinjiang Longquan to buy products from 1 December 2025 to 31 December 2027. This agreement is classified as a continuing connected transaction under the Hong Kong Stock Exchange Listing Rules, requiring reporting and announcement but exempt from independent shareholders’ approval due to the applicable percentage ratios.